Literature DB >> 20871136

A systematic evaluation of the dose-rate constant determined by photon spectrometry for 21 different models of low-energy photon-emitting brachytherapy sources.

Zhe Jay Chen1, Ravinder Nath.   

Abstract

The aim of this study was to perform a systematic comparison of the dose-rate constant (Λ) determined by the photon spectrometry technique (PST) with the consensus value ((CON)Λ) recommended by the American Association of Physicists in Medicine (AAPM) for 21 low-energy photon-emitting interstitial brachytherapy sources. A total of 63 interstitial brachytherapy sources (21 different models with 3 sources per model) containing either (125)I (14 models), (103)Pd (6 models) or (131)Cs (1 model) were included in this study. A PST described by Chen and Nath (2007 Med. Phys. 34 1412-30) was used to determine the dose-rate constant ((PST)Λ) for each source model. Source-dependent variations in (PST)Λ were analyzed systematically against the spectral characteristics of the emitted photons and the consensus values recommended by the AAPM brachytherapy subcommittee. The values of (PST)Λ for the encapsulated sources of (103)Pd, (125)I and (131)Cs varied from 0.661 to 0.678 cGyh(-1) U(-1), 0.959 to 1.024 cGyh(-1)U(-1) and 1.066 to 1.073 cGyh(-1)U(-1), respectively. The relative variation in (PST)Λ among the six (103)Pd source models, caused by variations in photon attenuation and in spatial distributions of radioactivity among the source models, was less than 3%. Greater variations in (PST)Λ were observed among the 14 (125)I source models; the maximum relative difference was over 6%. These variations were caused primarily by the presence of silver in some (125)I source models and, to a lesser degree, by the variations in photon attenuation and in spatial distribution of radioactivity among the source models. The presence of silver generates additional fluorescent x-rays with lower photon energies which caused the (PST)Λ value to vary from 0.959 to 1.019 cGyh(-1)U(-1) depending on the amount of silver used by a given source model. For those (125)I sources that contain no silver, their (PST)Λ was less variable and had values within 1% of 1.024 cGyh(-1)U(-1). For the 16 source models that currently have an AAPM recommended (CON)Λ value, the agreement between (PST)Λ and (CON)Λ was less than 2% for 15 models and was 2.6% for 1 (103)Pd source model. Excellent agreement between (PST)Λ and (CON)Λ was observed for all source models that currently have an AAPM recommended consensus dose-rate constant value. These results demonstrate that the PST is an accurate and robust technique for the determination of the dose-rate constant for low-energy brachytherapy sources.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20871136      PMCID: PMC3265933          DOI: 10.1088/0031-9155/55/20/004

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  23 in total

Review 1.  Permanent prostate brachytherapy: lessons learned, lessons to learn.

Authors:  L Potters
Journal:  Oncology (Williston Park)       Date:  2000-07       Impact factor: 2.990

2.  Impact of source-production revision on the dose-rate constant of 131Cs interstitial brachytherapy sources.

Authors:  Zhe Chen; Paul Bongiorni; Ravinder Nath
Journal:  Med Phys       Date:  2010-07       Impact factor: 4.071

3.  Silver fluorescent x-ray yield and its influence on the dose rate constant for nine low-energy brachytherapy source models.

Authors:  Ravinder Nath; Zhe Jay Chen
Journal:  Med Phys       Date:  2007-10       Impact factor: 4.071

4.  Photon spectrometry for the determination of the dose-rate constant of low-energy photon-emitting brachytherapy sources.

Authors:  Zhe Jay Chen; Ravinder Nath
Journal:  Med Phys       Date:  2007-04       Impact factor: 4.071

5.  Dosimetric characterization of a 131Cs brachytherapy source by thermoluminescence dosimetry in liquid water.

Authors:  Ramesh Tailor; Geoffrey Ibbott; Stephanie Lampe; Whitney Bivens Warren; Naresh Tolani
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

6.  Photon energy spectrum emitted by a novel polymer-encapsulated 103Pd source and its effect on the dose rate constant.

Authors:  Sabrina Khan; Zhe Jay Chen; Ravinder Nath
Journal:  Med Phys       Date:  2008-04       Impact factor: 4.071

7.  Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.

Authors:  H Ragde; L J Korb; A A Elgamal; G L Grado; B S Nadir
Journal:  Cancer       Date:  2000-07-01       Impact factor: 6.860

8.  Brachytherapy dosimetry parameters calculated for a 131Cs source.

Authors:  Mark J Rivard
Journal:  Med Phys       Date:  2007-02       Impact factor: 4.071

9.  Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation.

Authors:  S H Stokes
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-04-01       Impact factor: 7.038

10.  Dosimetric characterization of model Cs-1 Rev2 cesium-131 brachytherapy source in water phantoms and human tissues with MCNP5 Monte Carlo simulation.

Authors:  Jianhua Wang; Hualin Zhang
Journal:  Med Phys       Date:  2008-04       Impact factor: 4.071

View more
  2 in total

1.  Evaluation of (101)Rh as a brachytherapy source.

Authors:  Delaram Pakravan; Mahdi Ghorbani; Ali Soleimani Meigooni
Journal:  J Contemp Brachytherapy       Date:  2015-04-01

2.  Measurement of the strength of iodine-125 seed moving at unknown speed during implantation in brachytherapy.

Authors:  Kenichi Tanaka; Satoru Endo; Kunihiko Tateoka; Osamu Asanuma; Ken-Ichi Kamo; Kaori Sato; Hiromitsu Takeda; Masaru Takagi; Masato Hareyama; Jun Takada
Journal:  J Radiat Res       Date:  2013-06-30       Impact factor: 2.724

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.